*Dear Editor*,

Surface-exposed calreticulin (ecto-CRT) and secreted ATP have emerged as incontrovertible danger signals.^[@bib1],\ [@bib2],\ [@bib3]^ A surge in studies describing the impact of these danger signals has also spurred a tremendous interest in the discovery of signaling pathways regulating their 'emission\'. Recent research has shown that the pathways regulating the emission of these danger signals exhibit a certain degree of 'plasticity\' and context-dependency.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^ This applies mainly to the pathways regulating ecto-CRT emission and ATP secretion induced by mitoxantrone (MTX)^[@bib2]^ and hypericin-based photodynamic therapy (Hyp-PDT).^[@bib3],\ [@bib4],\ [@bib5]^

Irrespective of the inducers though, molecular components regulating endoplasmic reticulum (ER)-stress and autophagy have been found to form the 'core\' of pathways behind ecto-CRT and secreted ATP.^[@bib1],\ [@bib3],\ [@bib5]^ While ER-stress tends to regulate these pathways positively,^[@bib1],\ [@bib3]^ macroautophagy has recently emerged to play a more contextual role.^[@bib1],\ [@bib6]^ While on one hand, macroautophagy was found to positively regulate MTX-induced ATP secretion,^[@bib2]^ on the other we found that macroautophagy negatively regulates Hyp-PDT-induced ecto-CRT^[@bib6]^ (without affecting ATP secretion^[@bib6]^). This further increased our curiosity regarding the role of autophagy pathways behind ecto-CRT/secreted ATP. Interestingly, it was recently shown that the lysosomal protein LAMP1 can regulate MTX-induced ATP secretion.^[@bib2]^ We have previously shown that oxidative stress generated by Hyp-PDT along with macroautophagy can stimulate chaperone-mediated autophagy (CMA), a process mediated by the lysosomal protein, LAMP2A^[@bib7],\ [@bib8]^ Cells lacking LAMP2A were found to be extremely sensitized toward Hyp-PDT-induced apoptotic cell death, which is mediated by severe reactive oxygen species-induced ER stress.^[@bib7]^ On the back of these exciting results, we became curious about the impact this CMA-essential gene can have on cell-surface exposure of CRT and secretion of ATP.

To this end, we tested the ability of LAMP2A^+/+^ and LAMP2A^−/−^ cells to emit secreted ATP/ecto-CRT following MTX/Hyp-PDT treatments. MTX and Hyp-PDT induced significant secretion of ATP in LAMP2A^+/+^ cells as compared with the untreated cells ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). Similarly, the LAMP2A^−/−^ cells also retained their capacity to secrete ATP following MTX/Hyp-PDT treatment, to the same extent as the LAMP2A^+/+^ cells ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}).

Next, we analyzed the induction of ecto-CRT and found both MTX and Hyp-PDT to be potent inducers of ecto-CRT in the LAMP2A^+/+^ cells ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}), as expected.^[@bib4],\ [@bib5]^ Interestingly, we found that the LAMP2A^−/−^ cells exhibited a strong inability to emit ecto-CRT, not only following MTX/Hyp-PDT treatments but also in basal conditions ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). This complete abrogation of ecto-CRT in the absence of LAMP2A indicated an 'innate\' dysfunction of ecto-CRT trafficking pathway in these cells. It has been well established that cells lacking LAMP2A exhibit a compensatory rise in macroautophagy, under basal conditions, to counter the absence of CMA.^[@bib7],\ [@bib8]^ We had recently observed that ablation of macroautophagy (via ATG5-siRNA) increased Hyp-PDT-induced ecto-CRT.^[@bib6]^ Thus, we wondered whether we can rescue ecto-CRT emission in LAMP2A^−/−^ cells if we knockdown ATG5 (ATG5^KD^). ATG5^KD^ in LAMP2A^+/+^ cells ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}, left) further increased the induction of ecto-CRT after treatment (as compared with LAMP2A^+/+^ cells transfected with Scr-siRNA) ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}, right), especially after Hyp-PDT, as expected.^[@bib6]^ Contrary to expectations though, ATG5^KD^ in LAMP2A^−/−^ cells (∼50%^KD^; [Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}, left) failed to re-establish ecto-CRT, both under basal and treated conditions ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}, right). These results indicate that possibly the absence of CMA in LAMP2A^−/−^ cells underlies their inability to emit ecto-CRT (rather than compensatory rise in ATG5-regulated macroautophagy) -- a premise that needs to be comprehensively investigated.

In conclusion, we found that LAMP2A is dispensable for both MTX and Hyp-PDT-induced ATP secretion. However interestingly, we observed that the absence of LAMP2A abrogates ecto-CRT emission (in basal and MTX/Hyp-PDT treatment scenarios) -- a dysfunction that cannot be rescued by siRNA-based knock-down of ATG5. In future, it would be imperative to investigate whether there is a direct link between ecto-CRT emission and CMA induction.
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